MONTREAL, Aug. 4, 2022 /CNW Telbec/ - Certain shareholders (the "Opposing Shareholders") of Emerald Health Therapeutics Inc. ("Emerald") (CNSX:EMH.CN); (OTCQX:EMHTF), announce that they oppose the announced plan of arrangement (the "Plan") between Emerald and Skye Biosciences Inc. ("Skye") (OTC-BB:SKYE).
Read more at newswire.caGroup of Shareholders Oppose Plan of Arrangement Between Emerald Health Therapeutics and Skye Biosciences Inc.
Newswire.ca - Press Release
All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here